Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2

J Clin Invest. 2020 Nov 2;130(11):6187. doi: 10.1172/JCI144618.
No abstract available

Publication types

  • Retraction of Publication